🔴 Marker Therapeutics is trading 5.5% down today amid broader risk-off trading

Marker Therapeutics is trading at $1.21, down -5.47%, amid a broader risk-off session.

• The NASDAQ Composite is down 0.55%, with energy-driven inflation concerns weighing on equities.
• No clear company-specific announcement was identified for September 9, 2026; investor relations lists March 18, 2026, as its latest 2026 release.
• The move follows September 8’s 8.47% rebound, suggesting elevated volatility rather than a confirmed corporate catalyst.